Weekly seroconversion rate of the mRNA-1273 SARS-CoV-2 vaccine in haemodialysis patients
Open Access
- 9 June 2021
- journal article
- editorial
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 36 (9) , 1754-1755
Abstract
Dialysis-dependent chronic kidney disease (DD-CKD) patients have a deficient immune response that predisposes them to infections and an inadequate response to vaccinations [ 1]. In addition, they have a higher risk of contracting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in haemodialysis units, and once infected, they show greater mortality rates and longer hospital stays than the general population [ 2]. Moreover, this population’s seroconversion durability remains unknown, as antibody titers have been shown to decline with time [ 3], predisposing patients to potentially severe reinfections [ 4]. Therefore, some authors suggest that DD-CKD patients require close monitoring of post-vaccination seroconversion to determine optimal immunization schedules [ 5].Keywords
This publication has 12 references indexed in Scilit:
- Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant RecipientsJAMA, 2021
- Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccineThe Lancet, 2021
- SARS-CoV-2 antibody prevalence in England following the first peak of the pandemicNature Communications, 2021
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineNew England Journal of Medicine, 2021
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine CandidatesNew England Journal of Medicine, 2020
- Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older AdultsNew England Journal of Medicine, 2020
- A Longitudinal, 3-Month Serologic Assessment of SARS-CoV-2 Infections in a Belgian Hemodialysis FacilityClinical Journal of the American Society of Nephrology, 2020
- An mRNA Vaccine against SARS-CoV-2 — Preliminary ReportNew England Journal of Medicine, 2020
- Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech)Journal of Clinical Virology, 2020
- Basic Science and Dialysis: Disturbances of Acquired Immunity in Hemodialysis PatientsSeminars in Dialysis, 2007